💥 Zero Bullshit
Chapitre 03

Surely you can’t be serious.

At the Series D, international expansion was billed as a priority. But barely two years after buying Protifarm, the production site was shut and brought back to Dole. The subsidiary would make do with R&D.

In the meantime, Ÿnsect had also bought Jord in the US for $300K, renamed Ÿnsect Nebraska, through its US subsidiary Ÿnsect Inc., which sells insects for backyard chickens.

All of these entities are funded, at a loss, by the parent company.

Add to that France, where the finances are deteriorating badly. Contrary to what Les Echos, France’s leading business daily, claims9, 2022 revenue was much higher than €568K, but breaking even looks very, very far off.

  • 2019: €138K in revenue for a net result of -€9.22M
  • 2020: €10.5M / -€29.6M
  • 2021: €17.8M / -€36M
  • 2022: €3.23M / -€89.7M
  • 2023: €5.8M / -€79.7M

What a bunch of numpties at Les Echos, eh, unable to read the table available on Pappers, a French company-records website?
Well… Actually, it’s the other way round. 😅

Let’s take that famous year, 2021, the revenue record, and break it down. Here’s the revenue, in fact:

  • €271K re-invoiced to Ÿnsect Nebraska
  • €16.7K for Ÿnsect NL
  • And… €17.1M for SCI Vertycal, a French property-holding company.

In 2020, it was €10.3M for that same property company, and €2.5M in 2022.

What the actual fuck?

In 2023, actual revenue was €656K.